All In MedTech

Device Trial Radar · NCT06389916

Euclid Phoenix Lens Design Trial

Euclid Phoenix Lens Design Trial Phase 1

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

39

Actual

Start

Nov 1, 2023

Primary completion

May 9, 2024

Study completion May 9, 2024

Sponsor

Lead sponsor
Euclid Systems CorporationNot on our public-company list
Sponsor type
Industry
Collaborators
ClinTrialSolutions, LLC
First posted
Apr 29, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 6 years, up to 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The "first fit" success rate of the current Euclid orthokeratology "MAX" lens design will be compared to that of the new Euclid orthokeratology MAX "Phoenix" lens design in 30 children.

Conditions

  • Myopia
  • Cornea

Interventions

  • Euclid orthokeratology MAX (current design)Device

    The current lens design

  • Euclid orthokeratology MAX Phoenix (new design)Device

    The new lens design

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. First fit success rateTime frame: 1 month

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Insight Vision Center Optometry

    Costa Mesa, California

  • Dau Family Eye Care

    Saint Johns, Florida

  • Cornea and Contact Lens Institute of Minnesota

    Edina, Minnesota

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.